Flowcytometry in Chronic B-Cell Lymphoproliferative Disorders: A Retrospective Study from a Tertiary Oncology Centre, Trivandrum, India
Published: September 1, 2021 | DOI: https://doi.org/10.7860/JCDR/2021/46090.15375
CM Simi, Rekha A Nair, Priya Mary Jacob, AV Jayasudha
1. Medical Staff, Department of Obstetrics and Gynaecology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.
2. Medical Staff, Department of Obstetrics and Gynaecology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.
3. Medical Staff, Department of Obstetrics and Gynaecology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.
4. Medical Staff, Department of Obstetrics and Gynaecology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.
5. Director, Department of Obstetrics and Gynaecology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan.
Correspondence
Rekha A Nair,
Director, Department of Pathology, Regional Cancer Centre, Trivandrum, Kerala, India.
E-mail: drrekhanair@gmail.com
Non-tubal ectopic pregnancies are risk factors for maternal death and require prompt diagnosis and treatment. However, there are no established guidelines for their treatment because their rarity and care is individualized. We retrospectively reviewed the medical records of non-tubal ectopic pregnancies at our institution between May 2009 and September 2020. Thirty-four relevant cases were identified, including 14 interstitial, seven cervical, six peritoneal, three caesarean scars, two ovarian, and two rudimentary horn pregnancies; 23 of the 34 cases were diagnosed before treatment using ultrasound or magnetic resonance imaging. All patients were examined before nine weeks of gestation, and 17 were examined for a positive pregnancy test without any symptoms. In conclusion, in our hospital, non-tubal ectopic pregnancies were identified early, resulting in successful treatment without serious complications.
[
FULL TEXT ] | [ PDF]